EMA must improve the quality of its clinical trial reports

被引：20

作者：

Barbui, Corrado ^{[1
]}

Baschirotto, Cinzia ^{[1
]}

Cipriani, Andrea ^{[1
]}

机构：

[1] Univ Verona, WHO Collaborating Ctr Res & Training Mental Hlth, I-37100 Verona, Italy

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2011年 / 342卷

关键词：

DRUG; INFORMATION; PAROXETINE;

D O I：

10.1136/bmj.d2291

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页数：5

共 18 条

[1]

[Anonymous], 2010, LANCET, V375, P1753, DOI [10.1016/S0140-6736(10)60785-4, 10.1016/S0140-6736(10)60760-X]

[2]

[Anonymous], 2010, J CLIN EPIDEMIOL, DOI DOI 10.1016/j.jclinepi.2009.12.014

[3]

[Anonymous], ASS REP CIRC

[4] Transparency at the Food and Drug Administration. [J].

Asamoah, Afia K. ;

Sharfstein, Joshua M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (25) :2341-2343

[5] Suicide attempts in clinical trials with paroxetine randomised against placebo [J].

Aursnes, Ivar ;

Tvete, Ingunn Fride ;

Gaasemyr, Jorund ;

Natvig, Bent .

BMC MEDICINE, 2005, 3 (1)

[6] Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials [J].

Barbui, Corrado ;

Furukawa, Toshiaki A. ;

Cipriani, Andrea .

CANADIAN MEDICAL ASSOCIATION JOURNAL, 2008, 178 (03) :296-305

[7] CNS drugs approved by the centralised European procedure:: true innovation or dangerous stagnation? [J].

Barbui, Corrado ;

Cipriani, Andrea ;

Lintas, Camilla ;

Bertele, Vittorio ;

Garattini, Silvio .

PSYCHOPHARMACOLOGY, 2007, 190 (02) :265-268

[8] Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis [J].

Cipriani, Andrea ;

Furukawa, Toshiaki A. ;

Salanti, Georgia ;

Geddes, John R. ;

Higgins, Julian P. T. ;

Churchill, Rachel ;

Watanabe, Norio ;

Nakagawa, Atsuo ;

Omori, Ichiro M. ;

McGuire, Hugh ;

Tansella, Michele ;

Barbui, Corrado .

LANCET, 2009, 373 (9665) :746-758

[9] EMEA: For patients or for industry? [J].

Garattini, S .

PHARMACOECONOMICS, 2005, 23 (03) :207-208

[10] Light and shade in proposed revision of EU drug-regulatory legislation [J].

Garattini, S ;

Bertele', V ;

Bassi, LL .

LANCET, 2003, 361 (9358) :635-636

← 1 2 →